This skill recommends lifelong follow-up tests for cardiac myxoma and associated disease (testicular tumors, acromegaly, thyroid lesions) in patients with Carney complex. Use when managing a Cushing’s syndrome patient with a confirmed or suspected Carney complex diagnosis (e.g., spotty skin lentigines, cardiac myxoma, endocrine tumors).
Scanned 9/9/2026
Install to Claude Code
npx -y skills add dromlakhani/MD2SKILL --skill es-cushing-lifelong-follow-up-carney-complex --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Es Cushing Lifelong Follow Up Carney Complex?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-es-cushing-lifelong-follow-up-carney-complex)More formats (shields.io, HTML) on the badges page.
---
name: es-cushing-lifelong-follow-up-carney-complex
description: This skill recommends lifelong follow-up tests for cardiac myxoma and associated disease (testicular tumors, acromegaly, thyroid lesions) in patients with Carney complex. Use when managing a Cushing’s syndrome patient with a confirmed or suspected Carney complex diagnosis (e.g., spotty skin lentigines, cardiac myxoma, endocrine tumors).
---
# Lifelong Follow-Up Tests for Cardiac Myxoma and Associated Disease in Patients With Carney Complex
## STEP 1 — Gather Information
Confirm Carney complex diagnosis: obtain history of spotty skin pigmentation, cardiac myxoma, endocrine overactivity (e.g., Cushing’s syndrome, acromegaly), and family history; perform physical exam for lentigines, myxomas, testicular masses; review prior imaging and endocrine labs.
## STEP 2 — Rule In / Rule Out
Is Carney complex confirmed or strongly suspected? If no, discontinue this pathway; if yes, proceed to stratification.
## STEP 3 — Classify or Stratify
Determine which associated diseases to screen based on age, sex, and prior findings: all patients need cardiac myxoma surveillance; males add testicular tumor screening; all add acromegaly (IGF‑1) and thyroid lesion screening.
## STEP 4 — Decide
Order lifelong surveillance: cardiac echocardiogram every 1–2 years, testicular ultrasound annually (males), serum IGF‑1 annually, thyroid ultrasound or TSH annually; refer abnormal results to cardiology, urology, or endocrinology.
## Clinical Guardrails / Mimics / Pitfalls
Do not rely on symptoms alone—cardiac myxoma can be asymptomatic until embolic event; do not skip screening because the patient feels well; avoid confusing isolated cardiac myxoma without systemic Carney complex features, which does not require the same lifelong multimodal surveillance.
## Concrete Clinical Example
A 24‑year‑old man presents with Cushing’s syndrome due to primary pigmented nodular adrenal disease, spotty skin lentigines on lips, and a brother who died of cardiac myxoma at age 30; Carney complex is diagnosed, prompting initiation of annual echocardiogram, testicular ultrasound, IGF‑1, and thyroid ultrasound.
**Source:** Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!